This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Illumina Cambridge Limited, Illumina Corporation. Active years: 2023-2025.
Company Filing History:


Years Active: 2023-2025
Title: Ole Schulz-Trieglaff: Innovator in Deep Learning and Genetic Data Analysis
Introduction
Ole Schulz-Trieglaff is a prominent inventor based in Cambridge, GB. He has made significant contributions to the field of genetic data analysis through his innovative technologies. With a total of 2 patents, Schulz-Trieglaff has established himself as a key figure in the application of deep learning techniques to variant classification.
Latest Patents
One of his latest patents is a deep learning-based variant classifier. This technology operates directly on sequencing data and derives its own feature filters. It processes a plurality of aligned reads that span a target base position. The system combines elegant encoding of the reads with a lightweight analysis to produce good recall and precision using lightweight hardware. For instance, one million training examples of target base variant sites with 50 to 100 reads each can be trained on a single GPU card in less than 10 hours with good recall and precision. A single GPU card is desirable because it is an inexpensive computer that is almost universally within reach for users looking at genetic data. This technology is readily available on cloud-based platforms.
Career Highlights
Throughout his career, Ole Schulz-Trieglaff has worked with notable companies such as Illumina Corporation and Illumina Cambridge Limited. His work has focused on advancing the capabilities of genetic data analysis through innovative technological solutions.
Collaborations
Some of his coworkers include Anthony James Cox and Kai-How Farh. Their collaborative efforts have contributed to the development of cutting-edge technologies in the field.
Conclusion
Ole Schulz-Trieglaff's contributions to deep learning and genetic data analysis highlight his role as an influential inventor. His innovative approaches continue to shape the future of genetic research and technology.